Gennex Laboratories share news and announcements

BSE: 531739Pharmaceuticals & BiotechnologySmall Cap

₹8.70₹0.15 (1.69%)

Share price at the BSE close on 23 Oct 2026. Previous close ₹8.85.

52-week range of traded prices to 23 Oct 2026

₹7.05Low, 30 Mar 2026₹17.25High, 28 Oct 2025

Market cap: ₹211 Cr2,248th largest listed
P/E: 11.5
P/B: 0.9
Dividend yield: Nonein the last 12 months
ROE: 9.0%
ROCE: 7.0%
Debt to equity: 0.15
Volume, BSE: 2,30,459

Gennex Laboratories share news and announcements

553 announcements, routine notices left out, newest first. Page 3 of 12.

Aug 2024
- 5 Aug · Board meeting
  GENNEX LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2024 ,inter alia, to consider and approve With reference to the .... (opens in a new tab)
May 2024
- 30 May · Results
  In just concluded Meeting of Board of Directors, the Board approved and considered the following items: 1. Audited Standalone and Consolidated Financial results for the Quarter ended .... (opens in a new tab)
- 30 May · Board meeting
  In just concluded Meeting of Board of Directors, the Board Approved and considered the following items: 1. Audited Standalone & Consolidated Financial results for the quarter ended & .... (opens in a new tab)
- 21 May · Board meeting
  Meeting on 30 May 2024: audited results
- 21 May · Board meeting
  GENNEX LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2024 ,inter alia, to consider and approve 1. Audited Financial Statements .... (opens in a new tab)
Apr 2024
- 29 Apr · Compliance Certificate Under Regulation 40(9) & 40(10} Of The SEBI (Listing Obligation And Disclosure Requirements) Regulations, 2015 Of Gennex Laboratories Limited For The Year Ended March 31, Z024
  With reference to the above captioned subject matter, Pursuant to Regulation 40(9) & (10) of the SEBI (LODR), Regulations, 2015 enclosed please find the letter dated April 23, 2024 received .... (opens in a new tab)
- 25 Apr · Compliance Certificate Under Regulation 7(2) & 7(3) Of The SEBI (LODR) Regulations, 2015 Of Gennex Laboratories Limited For The Year Ended March 31, 2024
  With reference to the above captioned subject matter, we are hereby enclosing the Compliance Certificate pursuant to Regulation 7(2) and 7(3) of SEBI (LODR) Regulations, 2015 for the year .... (opens in a new tab)
Feb 2024
Jan 2024
- 27 Jan · Board meeting
  Read with Schedule III thereto, and in furtherance to our intimation dated 20/11/2023, 29/11/2023, and Board meeting outcome .... (opens in a new tab)
Dec 2023
Nov 2023
- 29 Nov · Board meeting
  GENNEX LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 02/12/2023 ,inter alia, to consider and approve This intimation is revision .... (opens in a new tab)
- 20 Nov · Board meeting
  Meeting on 2 Dec 2023: increase in authorised capital and preferential issue of shares
- 20 Nov · Board meeting
  GENNEX LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 02/12/2023 ,inter alia, to consider and approve We hereby inform you that .... (opens in a new tab)
- 20 Nov · Disclosure
  Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for JMS Mining Pvt Ltd (opens in a new tab)
- 14 Nov · Results
  In just concluded Meeting of Board of Directors, the Board approved and considered the following items: 1. Unaudited (Standalone and Consolidated) Financial Statements for the Quarter .... (opens in a new tab)
- 14 Nov · Board meeting
  In just concluded Meeting of Board of Directors, the Board Approved and considered the following items: 1. Unaudited (Standalone and Consolidated) Financial Statements for the Quarter .... (opens in a new tab)
- 14 Nov · Disclosure Under Regulation.23(9) Of SEBI (Listing Obligations And Disclosure Requirements) Regulation, 2015 Of Gennex Laboratories Limited
  Pursuant to provision of Regulation 23(9) of SEBI (LODR), 2015, we hereby submit the attached note on Related Party Transaction on Consolidated basis for the First half year ended September .... (opens in a new tab)
- 3 Nov · Board meeting
  Meeting on 14 Nov 2023: quarterly results
- 3 Nov · Board meeting
  GENNEX LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2023 ,inter alia, to consider and approve 1. Consider and adopt .... (opens in a new tab)
Oct 2023
Sep 2023
Aug 2023
- 29 Aug · Board meeting
  Meeting on 6 Sep 2023: annual general meeting
- 29 Aug · Board meeting
  GENNEX LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/09/2023 ,inter alia, to consider and approve With reference to the .... (opens in a new tab)
- 14 Aug · Results
  Unaudited Financial Results (Standalone and Consolidated) for the Quarter ended 30.06.2023 along with Limited Review Reports from the Statutory Auditors for that period as approved and .... (opens in a new tab)
- 14 Aug · Results
  In just concluded Meeting of Board of Directors, the Board Approved and considered the following items: 1. Unaudited (Standalone and Consolidated) Financial Statements for the Quarter .... (opens in a new tab)
- 9 Aug · Company Obtained Approval Of Additional Products From Drug Control Administration, Government Of Telangana;
  We are pleased to inform that the Company has received Approval from the Drug Control Administration, Government of Telangana granting manufacture of Additional products under Form 25. List .... (opens in a new tab)
- 3 Aug · Board meeting
  Meeting on 14 Aug 2023: quarterly results
- 3 Aug · Board meeting
  GENNEX LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2023 ,inter alia, to consider and approve With reference to the .... (opens in a new tab)
Jul 2023
- 12 Jul · Outcome Of The Right Issue Committee Meeting Of Gennex Laboratories Limited
  Right Issue Committee of the Company has inter-alia considered and approved the following matters: 1. Transition of 804,395 Partly Paid up Equity Shares in to Fully Paid up Equity Shares .... (opens in a new tab)
- 11 Jul · Company Obtained World Health Organization - Goods Manufacturing Practice (WHO-GMP) Certificate From Drug Control Administration, Government Of Telangana,
  We are pleased to inform the Company has received World Health Organization Good Manufacturing Practice (WHO-GMP) Certificate from the Drug Control Administration, Government of Telangana, .... (opens in a new tab)

Gennex Laboratories share news and announcements

Aug 2024

May 2024

Apr 2024

Feb 2024

Jan 2024

Dec 2023

Nov 2023

Oct 2023

Sep 2023

Aug 2023

Jul 2023